✦ LIBER ✦

PAR-1 ANTAGONIST VORAPAXAR IMPROVES GLOBAL THROMBOTIC STATUS IN PATIENTS WITH CORONARY DISEASE

✍ Scribed by Gorog, Diana A.; Christopoulos, Christos; Niespialowska-Steuden, Maria N.; Kozarski, Robert; Wilcox, Robert

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PAR-1 antagonist vorapaxar favorably imp

✍ Rosser, G.; Tricoci, P.; Morrow, D.; Christopoulos, C.; Niespialowska-Steuden, M 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 228 KB

Pharmacokinetics of the novel PAR-1 anta

✍ Paul Statkevich, Teddy Kosoglou… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 199 KB

Pharmacokinetics and pharmacodynamics of

✍ Kosoglou, Teddy; Kraft, Walter K.; Kumar, Bharath; Statkevich, Paul; Xuan, Fengj 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 221 KB

Vorapaxar in patients with peripheral ar

✍ Jones, William Schuyler; Tricoci, Pierluigi; Huang, Zhen; Moliterno, David J.; H 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 356 KB

Improved regional and global diastolic p

✍ Kyoichi Mizuno; Ko Arakawa; Toshio Shibuya; Kenji Horiuchi; Hirosuke Matui; Bonp 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 516 KB

Interleukin-1 Receptor Antagonist: A Sen

✍ Giuseppe Patti; Andrea D'Ambrosio; Aldo Dobrina; Giordano Dicuonzo; Carlo Giansa 📂 Article 📅 2002 🏛 Springer US 🌐 English ⚖ 101 KB